Cargando…
Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma
We have used cDNA arrays to investigate gene expression patterns in peripheral blood mononuclear cells from patients with leukemic forms of cutaneous T cell lymphoma, primarily Sezary syndrome (SS). When expression data for patients with high blood tumor burden (Sezary cells >60% of the lymphocyt...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193901/ https://www.ncbi.nlm.nih.gov/pubmed/12782714 http://dx.doi.org/10.1084/jem.20021726 |
_version_ | 1782147578905755648 |
---|---|
author | Kari, Laszlo Loboda, Andrey Nebozhyn, Michael Rook, Alain H. Vonderheid, Eric C. Nichols, Calen Virok, Dezso Chang, Celia Horng, Wen-Hwai Johnston, James Wysocka, Maria Showe, Michael K. Showe, Louise C. |
author_facet | Kari, Laszlo Loboda, Andrey Nebozhyn, Michael Rook, Alain H. Vonderheid, Eric C. Nichols, Calen Virok, Dezso Chang, Celia Horng, Wen-Hwai Johnston, James Wysocka, Maria Showe, Michael K. Showe, Louise C. |
author_sort | Kari, Laszlo |
collection | PubMed |
description | We have used cDNA arrays to investigate gene expression patterns in peripheral blood mononuclear cells from patients with leukemic forms of cutaneous T cell lymphoma, primarily Sezary syndrome (SS). When expression data for patients with high blood tumor burden (Sezary cells >60% of the lymphocytes) and healthy controls are compared by Student's t test, at P < 0.01, we find 385 genes to be differentially expressed. Highly overexpressed genes include Th2 cells–specific transcription factors Gata-3 and Jun B, as well as integrin β1, proteoglycan 2, the RhoB oncogene, and dual specificity phosphatase 1. Highly underexpressed genes include CD26, Stat-4, and the IL-1 receptors. Message for plastin-T, not normally expressed in lymphoid tissue, is detected only in patient samples and may provide a new marker for diagnosis. Using penalized discriminant analysis, we have identified a panel of eight genes that can distinguish SS in patients with as few as 5% circulating tumor cells. This suggests that, even in early disease, Sezary cells produce chemokines and cytokines that induce an expression profile in the peripheral blood distinctive to SS. Finally, we show that using 10 genes, we can identify a class of patients who will succumb within six months of sampling regardless of their tumor burden. |
format | Text |
id | pubmed-2193901 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2003 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21939012008-04-11 Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma Kari, Laszlo Loboda, Andrey Nebozhyn, Michael Rook, Alain H. Vonderheid, Eric C. Nichols, Calen Virok, Dezso Chang, Celia Horng, Wen-Hwai Johnston, James Wysocka, Maria Showe, Michael K. Showe, Louise C. J Exp Med Article We have used cDNA arrays to investigate gene expression patterns in peripheral blood mononuclear cells from patients with leukemic forms of cutaneous T cell lymphoma, primarily Sezary syndrome (SS). When expression data for patients with high blood tumor burden (Sezary cells >60% of the lymphocytes) and healthy controls are compared by Student's t test, at P < 0.01, we find 385 genes to be differentially expressed. Highly overexpressed genes include Th2 cells–specific transcription factors Gata-3 and Jun B, as well as integrin β1, proteoglycan 2, the RhoB oncogene, and dual specificity phosphatase 1. Highly underexpressed genes include CD26, Stat-4, and the IL-1 receptors. Message for plastin-T, not normally expressed in lymphoid tissue, is detected only in patient samples and may provide a new marker for diagnosis. Using penalized discriminant analysis, we have identified a panel of eight genes that can distinguish SS in patients with as few as 5% circulating tumor cells. This suggests that, even in early disease, Sezary cells produce chemokines and cytokines that induce an expression profile in the peripheral blood distinctive to SS. Finally, we show that using 10 genes, we can identify a class of patients who will succumb within six months of sampling regardless of their tumor burden. The Rockefeller University Press 2003-06-02 /pmc/articles/PMC2193901/ /pubmed/12782714 http://dx.doi.org/10.1084/jem.20021726 Text en Copyright © 2003, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Kari, Laszlo Loboda, Andrey Nebozhyn, Michael Rook, Alain H. Vonderheid, Eric C. Nichols, Calen Virok, Dezso Chang, Celia Horng, Wen-Hwai Johnston, James Wysocka, Maria Showe, Michael K. Showe, Louise C. Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma |
title | Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma |
title_full | Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma |
title_fullStr | Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma |
title_full_unstemmed | Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma |
title_short | Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma |
title_sort | classification and prediction of survival in patients with the leukemic phase of cutaneous t cell lymphoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193901/ https://www.ncbi.nlm.nih.gov/pubmed/12782714 http://dx.doi.org/10.1084/jem.20021726 |
work_keys_str_mv | AT karilaszlo classificationandpredictionofsurvivalinpatientswiththeleukemicphaseofcutaneoustcelllymphoma AT lobodaandrey classificationandpredictionofsurvivalinpatientswiththeleukemicphaseofcutaneoustcelllymphoma AT nebozhynmichael classificationandpredictionofsurvivalinpatientswiththeleukemicphaseofcutaneoustcelllymphoma AT rookalainh classificationandpredictionofsurvivalinpatientswiththeleukemicphaseofcutaneoustcelllymphoma AT vonderheidericc classificationandpredictionofsurvivalinpatientswiththeleukemicphaseofcutaneoustcelllymphoma AT nicholscalen classificationandpredictionofsurvivalinpatientswiththeleukemicphaseofcutaneoustcelllymphoma AT virokdezso classificationandpredictionofsurvivalinpatientswiththeleukemicphaseofcutaneoustcelllymphoma AT changcelia classificationandpredictionofsurvivalinpatientswiththeleukemicphaseofcutaneoustcelllymphoma AT horngwenhwai classificationandpredictionofsurvivalinpatientswiththeleukemicphaseofcutaneoustcelllymphoma AT johnstonjames classificationandpredictionofsurvivalinpatientswiththeleukemicphaseofcutaneoustcelllymphoma AT wysockamaria classificationandpredictionofsurvivalinpatientswiththeleukemicphaseofcutaneoustcelllymphoma AT showemichaelk classificationandpredictionofsurvivalinpatientswiththeleukemicphaseofcutaneoustcelllymphoma AT showelouisec classificationandpredictionofsurvivalinpatientswiththeleukemicphaseofcutaneoustcelllymphoma |